• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  04/30/2013
Trade Name:  Seroquel and Seroquel XR
Generic Name or Proper Name (*):  quetiapine
Indications Studied:  Bipolar depression
Label Changes Summary:  * Efficacy was not established in an 8-week placebo-controlled monotherapy trial of Seroquel XR in children and adolescents 10-17 years with bipolar depression.* In the same study patients treated with Seroquel XR exhibited metabolic changes, weight gain, and increases in blood pressure and heart rate.* The most commonly observed adverse reactions were dizziness 7%, diarrhea 5%, fatigue 5% and nausea 5% * Information on adverse reactions, clinical tria * Postmarketing study
Product Labeling:  Labeling  Opens a new window
Sponsor:  AstraZeneca
Therapeutic Category:  Antipsychotic